ODC 0501

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameODC 0501
Drug Alias NameDC vaccine-ODC TherapyDendritic cell vaccine-ODC TherapyODC-0501
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasm MetastasisMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBaylor Scott & White Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaylor Scott & White Research InstituteBaylor Research Institute Llc
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisMelanoma

Other Information

ATC CodeN/A
Related LinksN/A